UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Kaitlyn Wald, MD

Title(s)Clinical Fellow, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wald KA, Shahine LK, Lamb JD, Marshall LA, Hickok LR. High incidence of diminished ovarian reserve in young unexplained recurrent pregnancy loss patients. Gynecol Endocrinol. 2020 Apr 11; 1-3. PMID: 32279576.
      View in: PubMed
    2. Letourneau JM, Wald K, Sinha N, Juarez-Hernandez F, Harris E, Cedars MI, McCulloch CE, Dolezal M, Chien AJ, Rosen MP. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer. 2020 Feb 01; 126(3):487-495. PMID: 31639215.
      View in: PubMed
    3. Wald K, Letourneau J, Eshima-McKay R, Monks J, Mok-Lin E, Cedars M, Rosen M. Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations. J Assist Reprod Genet. 2019 Oct; 36(10):2087-2094. PMID: 31396851.
      View in: PubMed
    4. Wald K, Cakmak H, Mok-Lin E, Cedars M, Rosen M, Letourneau J. Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield. J Assist Reprod Genet. 2019 Jun; 36(6):1161-1168. PMID: 31127475.
      View in: PubMed
    5. Wald K, Cakmak H, Noel M. mTOR inhibitor sirolimus negatively impacts in vitro fertilization outcomes. J Assist Reprod Genet. 2019 May; 36(5):947-950. PMID: 30911930.
      View in: PubMed
    6. Letourneau JM, Sinha N, Wald K, Harris E, Quinn M, Imbar T, Mok-Lin E, Chien AJ, Rosen M. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod. 2017 10 01; 32(10):2123-2129. PMID: 28938748.
      View in: PubMed